Skip to main content
Clinical Trials/NCT04103931
NCT04103931
Completed
N/A

Pilot Randomized Trial of a Patient Decision Aid for Treatment of Aortic Stenosis

Massachusetts General Hospital2 sites in 1 country67 target enrollmentSeptember 23, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Aortic Valve Stenosis
Sponsor
Massachusetts General Hospital
Enrollment
67
Locations
2
Primary Endpoint
Knowledge score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This project will evaluate the impact of a patient decision aid created by the American College of Cardiology for patients considering treatment of aortic stenosis. The decision aid describes surgical aortic valve replacement (SAVR) surgery and transcatheter valve replacement surgery (TAVR).

Detailed Description

The pilot trial will enroll patients who are coming in to see a valve specialist (cardiac surgeon or interventional cardiologist) to discuss treatment options for aortic stenosis. The study will recruit patients at Massachusetts General Hospital or at the University of Colorado Health Heart and Vascular Center, Anschutz Medical in Denver, Colorado and randomly assign them to usual care arm or decision aid arm. The decision aid will be given to the participant in clinic at the time of their appointment. Patient participants in both arms will be asked to complete a short survey after the visit. The survey will assess knowledge, treatment preference, shared decision making (SDM), and decisional conflict. Analyses will compare the two arms on these outcomes to generate preliminary data on impact of the intervention.

Registry
clinicaltrials.gov
Start Date
September 23, 2019
End Date
September 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Karen Sepucha

Associate Professor

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Adults 18-85 years only
  • English speaking
  • Severe aortic stenosis, defined as an aortic valve area \< 1 cm2
  • Never had AVR or who had previous AVR \> 6 months previous
  • Patients perceived by the clinician to be at low or intermediate risk for SAVR

Exclusion Criteria

  • Concomitant disease of another heart valve or the aorta that required either transcatheter or surgical intervention

Outcomes

Primary Outcomes

Knowledge score

Time Frame: About 1 week after receiving the decision aid

Patients will complete 6 multiple choice knowledge items and a total knowledge score (0-100%) will be created by summing the number of correct responses and dividing by the number of items.

Secondary Outcomes

  • Treatment Preference(About 1 week after receiving the decision aid)
  • Shared Decision Making Process score(About 1 week after receiving the decision aid)
  • Treatment received(12-21 weeks post visit)

Study Sites (2)

Loading locations...

Similar Trials